Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.38 - $0.87 $410 - $940
-1,081 Reduced 3.58%
29,139 $11,000
Q3 2022

Nov 14, 2022

BUY
$0.83 - $132.53 $14,774 - $2.36 Million
17,800 Added 143.32%
30,220 $23,000
Q2 2022

Aug 12, 2022

BUY
$0.94 - $1.63 $11,674 - $20,244
12,420 New
12,420 $13,000

About Bluejay Diagnostics, Inc.


  • Ticker BJDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,152,300
  • Market Cap $75.6M
  • Description
  • Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...
More about BJDX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.